IntelliHep Company
Alzheimer and cancer .IntelliHep is exploiting novel technologies and intellectual property to deliver new heparin-based glycans as novel drug leads for specific diseases including Alzheimer’s disease and cancer. This is being achieved through in-house R&D and the development of strategic collaborative alliances with external partners.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
Undisclosed
Employees Number:
1-10
Funding Status:
N/A
Investors Number:
1
Last Funding Type:
Non-equity Assistance
Register and Claim Ownership